Pembrolizumab
#
Find similar titles
- (rev. 3)
- Hyungyong Kim
Structured data
Pembrolizumab (formerly MK-3475 and Lambrolizumab, trade name Keytruda, 키트루다) is a humanized antibody used in Cancer immunotherapy. It blocks a protective mechanism on cancer cells, and allows the Immune system to destroy those cancer cells. It targets PD-1 receptor. (https://en.wikipedia.org/wiki/Pembrolizumab)
관련정보
- Keytruda – 범용 항암치료제의 등장인가
- 미 FDA, 조직과 무관한(tissue-independent) 항암제 신속승인 : 키트루다의 약물 사용 범위 확대
Incoming Links #
Related Articles (Article 0) #
Suggested Pages #
- 0.183 Cytokine release syndrome
- 0.080 pVAC-Seq
- 0.062 CloudNeo
- 0.025 Atezolizumab
- 0.025 April 19
- 0.025 Lymphocyte
- 0.025 Granulocyte
- 0.025 Hyuna Kim
- 0.025 Interleukin
- 0.025 Durvalumab
- More suggestions...